IL228817A0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
IL228817A0
IL228817A0 IL228817A IL22881713A IL228817A0 IL 228817 A0 IL228817 A0 IL 228817A0 IL 228817 A IL228817 A IL 228817A IL 22881713 A IL22881713 A IL 22881713A IL 228817 A0 IL228817 A0 IL 228817A0
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IL228817A
Other languages
Hebrew (he)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41327301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL228817(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of IL228817A0 publication Critical patent/IL228817A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL228817A 2008-07-28 2013-10-10 Pharmaceutical composition IL228817A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008194219 2008-07-28
PCT/JP2009/063708 WO2010013823A2 (en) 2008-07-28 2009-07-27 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
IL228817A0 true IL228817A0 (en) 2013-12-31

Family

ID=41327301

Family Applications (2)

Application Number Title Priority Date Filing Date
IL210735A IL210735A0 (en) 2008-07-28 2011-01-18 Pharmaceutical composition
IL228817A IL228817A0 (en) 2008-07-28 2013-10-10 Pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL210735A IL210735A0 (en) 2008-07-28 2011-01-18 Pharmaceutical composition

Country Status (29)

Country Link
US (2) US9186411B2 (en)
EP (2) EP2564833B1 (en)
JP (2) JP5295356B2 (en)
KR (1) KR20110042334A (en)
CN (3) CN102743330B (en)
AR (1) AR072842A1 (en)
AU (1) AU2009277443A1 (en)
BR (1) BRPI0916689A2 (en)
CA (2) CA2732243C (en)
CL (1) CL2011000170A1 (en)
CO (1) CO6290638A2 (en)
CR (1) CR20110110A (en)
DO (2) DOP2011000033A (en)
EA (2) EA201201451A1 (en)
EC (1) ECSP11010855A (en)
ES (2) ES2669592T3 (en)
GE (2) GEP20146166B (en)
IL (2) IL210735A0 (en)
MA (1) MA32556B1 (en)
MX (1) MX2011000757A (en)
MY (2) MY169461A (en)
NZ (2) NZ591344A (en)
PE (3) PE20141585A1 (en)
SG (1) SG186685A1 (en)
TW (2) TW201010992A (en)
UA (1) UA103332C2 (en)
UY (1) UY32008A (en)
WO (1) WO2010013823A2 (en)
ZA (1) ZA201101198B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013122260A1 (en) 2012-02-15 2013-08-22 Takeda Pharmaceutical Company Limited Tablet
MX2014015269A (en) 2012-06-27 2015-02-20 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts.
TWI536992B (en) 2012-09-19 2016-06-11 Taiho Pharmaceutical Co Ltd And a medicinal composition for oral administration of improved elution and / or absorption
EP3632482A1 (en) * 2013-03-14 2020-04-08 Allergan, Inc. Polymer system for securing implants in syringe needles
CN105330647A (en) * 2014-08-14 2016-02-17 江苏柯菲平医药股份有限公司 Pyrrole sulfonamide derivative, preparation method and medical application thereof
CN105985278A (en) * 2015-01-27 2016-10-05 江苏柯菲平医药股份有限公司 Pyrrole sulfonyl derivatives, preparation method and medicinal application thereof
MA41850A (en) 2015-03-31 2018-02-06 Takeda Pharmaceuticals Co NEW PHARMACEUTICAL USES
ES2977953T3 (en) 2015-07-30 2024-09-03 Takeda Pharmaceuticals Co Compressed
CN105106203B (en) * 2015-08-17 2019-04-05 江苏豪森药业集团有限公司 Pharmaceutical composition of Vonoprazan fumarate and preparation method thereof
CN105030720B (en) * 2015-08-26 2019-12-10 迪沙药业集团有限公司 vonoprazan fumarate enteric-coated tablet and preparation method thereof
CN105030725B (en) * 2015-08-26 2019-12-10 迪沙药业集团有限公司 Vonoprazan fumarate enteric-coated composition and preparation method thereof
CN107224438B (en) * 2016-03-25 2021-04-06 江苏豪森药业集团有限公司 Vonoprazan fumarate pharmaceutical composition
CN110072518B (en) * 2016-10-12 2021-10-26 细胞内治疗公司 Amorphous solid dispersion
CN106580903B (en) * 2016-11-17 2019-12-13 江苏豪森药业集团有限公司 Roxithromycin sustained-release pharmaceutical composition
CN106860852A (en) * 2017-02-17 2017-06-20 王清华 A kind of mucus Western medicine for combined treatment stomach trouble
EP3630084A1 (en) 2017-05-31 2020-04-08 Boehringer Ingelheim International GmbH Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
SG11202000136YA (en) 2017-07-10 2020-02-27 Takeda Pharmaceuticals Co Preparation comprising vonoprazan
CN108558831B (en) * 2018-06-08 2021-07-27 上海璃道医药科技有限公司 Substituted pyrrole-4-alkylamine compound and application thereof
KR102126576B1 (en) 2018-09-19 2020-06-24 주식회사 대웅제약 Manufacturing method for 4-methoxypyrrole derivatives
CN109288722B (en) * 2018-11-09 2021-03-30 伯德创研(广州)生物科技有限公司 Color-changing and skin-color-correcting foundation and preparation method thereof
CN110538153B (en) * 2019-09-26 2022-04-26 扬子江药业集团四川海蓉药业有限公司 High-stability and quick-release solid preparation and preparation method thereof
CN111973565A (en) * 2020-07-07 2020-11-24 南京海纳医药科技股份有限公司 Vonoprazan fumarate-containing tablet and dissolution rate determination method thereof
CN111943932B (en) * 2020-08-06 2023-07-14 四川国康药业有限公司 3-pyridine sulfonyl-1-N-hetero pyrrole derivative capable of treating peptic ulcer and preparation method and application thereof
CN114853728B (en) * 2022-05-07 2023-11-07 四川制药制剂有限公司 Vonopraz fumarate tablet and preparation method thereof
CN115364065B (en) * 2022-08-23 2024-03-15 宁波高新区美诺华医药创新研究院有限公司 Furanolas fumarate green sheet
CN117462507B (en) * 2023-12-28 2024-03-15 山东齐都药业有限公司 Vonola fumarate crude drug composition and preparation method thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2844351B2 (en) 1989-07-13 1999-01-06 株式会社科薬 Aqueous solution of stable polymyxin antibiotics
US5422362A (en) 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis
TW483763B (en) 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
FR2745500B1 (en) 1996-03-04 1998-04-03 Synthelabo SUSTAINED RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING MIZOLASTINE
US5834503A (en) 1996-06-14 1998-11-10 Qlt Phototherapeutics, Inc. Methods to treat arterial plaque
FR2752162B1 (en) 1996-08-07 1998-11-06 Jouveinal Lab TRIMEBUTINE FILM MALEATE TABLET
ATE241341T1 (en) * 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd STABILIZED PHARMACEUTICAL COMPOSITION
JP4730985B2 (en) 1997-09-10 2011-07-20 武田薬品工業株式会社 Stabilized pharmaceutical formulation
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
DE60125026T2 (en) 2000-03-23 2007-06-28 Takeda Pharmaceutical Co. Ltd. FLUOROISOCHINOLINE DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE
US20050004139A1 (en) * 2001-07-30 2005-01-06 Takeshi Inamori Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient
CN1571664A (en) * 2001-10-17 2005-01-26 久光制药株式会社 Percutaneous absorption preparations
AU2003217820A1 (en) * 2002-02-28 2003-09-16 The Penn State Research Foundation Periocular drug delivery for diabetic retinopathy
DK1870100T3 (en) 2002-03-07 2012-05-14 Boehringer Ingelheim Int 3 - [(2 - {[4- (hexyloxycarbonylamino-imino-methyl) phenylamino] methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] -propionic acid ethyl ester methanesulfonate
US6818662B2 (en) 2002-05-28 2004-11-16 Taisho Pharmaceutical Co., Ltd. Pharmaceutical composition
DE10233108A1 (en) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Delayed pain reliever containing tilidine and a light stabilizer
EP1572164A2 (en) * 2002-12-18 2005-09-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
TW200503783A (en) 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
EP1648416A4 (en) 2003-07-18 2012-03-28 Santarus Inc Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE10337697A1 (en) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablet containing 3 - [(2 - {[4- (hexyloxycarbonylamino-iminomethyl) -phenyl-amino] -methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] - propionic acid ethyl ester or its salts
JP2005263788A (en) 2004-02-17 2005-09-29 Sankyo Co Ltd Stabilized pharmaceutical composition containing indoline compound
JP5168712B2 (en) 2004-04-01 2013-03-27 味の素株式会社 Nateglinide-containing preparation
JP2006001912A (en) 2004-06-21 2006-01-05 Chugai Pharmaceut Co Ltd Method for stabilizing protein preparation
JP5173192B2 (en) 2004-09-30 2013-03-27 武田薬品工業株式会社 Proton pump inhibitor
CA2582300A1 (en) 2004-10-05 2006-04-13 Altana Pharma Ag Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
JP5188181B2 (en) 2005-08-25 2013-04-24 協和発酵バイオ株式会社 Composition for suppressing increase in blood alcohol concentration
ES2364498T3 (en) * 2005-08-30 2011-09-05 Takeda Pharmaceutical Company Limited INHIBITOR OF THE ACID SECRETION.
CN101389317A (en) * 2005-12-28 2009-03-18 武田药品工业株式会社 Controlled release solid preparation
CN101516367A (en) * 2006-09-15 2009-08-26 安斯泰来制药有限公司 Solid pharmaceutical composition for optically stable ramosetron
JP5074052B2 (en) 2007-02-13 2012-11-14 有限会社愛和ライト Game machine
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
AR068538A1 (en) 2007-09-28 2009-11-18 Takeda Pharmaceutical 5-MEMBER HETEROCICLIC COMPOUND WITH SUPPRESSING ACTIVITY OF THE ACID SECRETION
KR101559597B1 (en) 2007-09-28 2015-10-12 다케다 야쿠힌 고교 가부시키가이샤 5-membered heterocyclic compound
EP2226075A1 (en) 2007-11-22 2010-09-08 The University of Tokyo Material for preventing tissue adhesion and material for preventing joint contracture

Also Published As

Publication number Publication date
EP2564833B1 (en) 2017-12-20
CL2011000170A1 (en) 2011-06-10
NZ591344A (en) 2013-03-28
ECSP11010855A (en) 2011-03-31
PE20110591A1 (en) 2011-09-15
WO2010013823A3 (en) 2010-04-15
EA201170272A1 (en) 2011-10-31
CA2732243C (en) 2016-11-29
BRPI0916689A2 (en) 2015-11-17
TW201010992A (en) 2010-03-16
UA103332C2 (en) 2013-10-10
MA32556B1 (en) 2011-08-01
GEP20146122B (en) 2014-07-25
AR072842A1 (en) 2010-09-22
GEP20146166B (en) 2014-09-25
MX2011000757A (en) 2011-02-24
CA2732243A1 (en) 2010-02-04
IL210735A0 (en) 2011-03-31
UY32008A (en) 2010-02-26
TW201431552A (en) 2014-08-16
CN104784180A (en) 2015-07-22
JP2011529445A (en) 2011-12-08
AU2009277443A1 (en) 2010-02-04
MY169461A (en) 2019-04-11
ES2660962T3 (en) 2018-03-26
KR20110042334A (en) 2011-04-26
CN102164581A (en) 2011-08-24
JP5593363B2 (en) 2014-09-24
CA2936400C (en) 2018-03-27
EP2309985B1 (en) 2018-03-14
ES2669592T3 (en) 2018-05-28
CN102743330B (en) 2016-03-23
NZ602592A (en) 2014-01-31
PE20141585A1 (en) 2014-11-13
JP5295356B2 (en) 2013-09-18
SG186685A1 (en) 2013-01-30
US20110124687A1 (en) 2011-05-26
MY156305A (en) 2016-01-29
EP2564833A1 (en) 2013-03-06
CA2936400A1 (en) 2010-02-04
EP2309985A2 (en) 2011-04-20
JP2013047239A (en) 2013-03-07
US20130261156A1 (en) 2013-10-03
DOP2013000172A (en) 2013-11-15
CO6290638A2 (en) 2011-06-20
ZA201101198B (en) 2012-05-30
EA201201451A1 (en) 2013-07-30
PE20140977A1 (en) 2014-08-20
DOP2011000033A (en) 2011-04-15
WO2010013823A2 (en) 2010-02-04
CR20110110A (en) 2011-04-28
US9186411B2 (en) 2015-11-17
CN102743330A (en) 2012-10-24

Similar Documents

Publication Publication Date Title
HUS1800007I1 (en) Pharmaceutical composition
IL228817A0 (en) Pharmaceutical composition
EP2240022A4 (en) Pharmaceutical compositions
GB0814695D0 (en) Pharmaceutical compositions
EP2133095A4 (en) Pharmaceutical composition
EP2133094A4 (en) Pharmaceutical composition
EP2373681A4 (en) Pharmaceutical compositions
EP2191826A4 (en) Pharmaceutical composition
PL2323623T3 (en) Pharmaceutical compositions
IL200125A0 (en) Pharmaceutical composition
EP2236149A4 (en) Medicinal composition
EP2224805A4 (en) Pharmaceutical composition
EP2224915A4 (en) Pharmaceutical composition
ZA201102715B (en) Solid pharmaceutical composition
IL208387A0 (en) Pharmaceutical composition
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) Pharmaceutical composition
ZA201100871B (en) Solid pharmaceutical composition
EP2156832A4 (en) Pharmaceutical composition
ZA201006224B (en) Pharmaceutical composition
EP2327406A4 (en) Stabilized pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
IL206487A0 (en) Pharmaceutical compositions
EP2224806A4 (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition